illuccix 68Ga-PSMA-11 Total Body PET-CT
BAMF-2022-03
Phase 1 small_molecule active
Quick answer
illuccix 68Ga-PSMA-11 Total Body PET-CT for Metastatic Castration-resistant Prostate Cancer is a Phase 1 program (small_molecule) at Telix Pharmaceuticals Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Telix Pharmaceuticals Ltd
- Indication
- Metastatic Castration-resistant Prostate Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active